182 related articles for article (PubMed ID: 30427558)
1. Selective Inhibitors of a Human Prolyl Hydroxylase (OGFOD1) Involved in Ribosomal Decoding.
Thinnes CC; Lohans CT; Abboud MI; Yeh TL; Tumber A; Nowak RP; Attwood M; Cockman ME; Oppermann U; Loenarz C; Schofield CJ
Chemistry; 2019 Feb; 25(8):2019-2024. PubMed ID: 30427558
[TBL] [Abstract][Full Text] [Related]
2. Structure of the ribosomal oxygenase OGFOD1 provides insights into the regio- and stereoselectivity of prolyl hydroxylases.
Horita S; Scotti JS; Thinnes C; Mottaghi-Taromsari YS; Thalhammer A; Ge W; Aik W; Loenarz C; Schofield CJ; McDonough MA
Structure; 2015 Apr; 23(4):639-52. PubMed ID: 25728928
[TBL] [Abstract][Full Text] [Related]
3. OGFOD1 catalyzes prolyl hydroxylation of RPS23 and is involved in translation control and stress granule formation.
Singleton RS; Liu-Yi P; Formenti F; Ge W; Sekirnik R; Fischer R; Adam J; Pollard PJ; Wolf A; Thalhammer A; Loenarz C; Flashman E; Yamamoto A; Coleman ML; Kessler BM; Wappner P; Schofield CJ; Ratcliffe PJ; Cockman ME
Proc Natl Acad Sci U S A; 2014 Mar; 111(11):4031-6. PubMed ID: 24550447
[TBL] [Abstract][Full Text] [Related]
4. Recent Advances in Developing Inhibitors for Hypoxia-Inducible Factor Prolyl Hydroxylases and Their Therapeutic Implications.
Kim SY; Yang EG
Molecules; 2015 Nov; 20(11):20551-68. PubMed ID: 26610437
[TBL] [Abstract][Full Text] [Related]
5. Structural Basis of Prolyl Hydroxylase Domain Inhibition by Molidustat.
Figg WD; McDonough MA; Chowdhury R; Nakashima Y; Zhang Z; Holt-Martyn JP; Krajnc A; Schofield CJ
ChemMedChem; 2021 Jul; 16(13):2082-2088. PubMed ID: 33792169
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of a viral prolyl hydroxylase.
Langley GW; Abboud MI; Lohans CT; Schofield CJ
Bioorg Med Chem; 2019 Jun; 27(12):2405-2412. PubMed ID: 30737136
[TBL] [Abstract][Full Text] [Related]
7. The ribosomal prolyl-hydroxylase OGFOD1 decreases during cardiac differentiation and modulates translation and splicing.
Stoehr A; Kennedy L; Yang Y; Patel S; Lin Y; Linask KL; Fergusson M; Zhu J; Gucek M; Zou J; Murphy E
JCI Insight; 2019 May; 5(13):. PubMed ID: 31112528
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of JMJD6 by 2-Oxoglutarate Mimics.
Islam MS; Thinnes CC; Holt-Martyn JP; Chowdhury R; McDonough MA; Schofield CJ
ChemMedChem; 2022 Jan; 17(1):e202100398. PubMed ID: 34581506
[TBL] [Abstract][Full Text] [Related]
9. Complement C1q is hydroxylated by collagen prolyl 4 hydroxylase and is sensitive to off-target inhibition by prolyl hydroxylase domain inhibitors that stabilize hypoxia-inducible factor.
Kiriakidis S; Hoer SS; Burrows N; Biddlecome G; Khan MN; Thinnes CC; Schofield CJ; Rogers N; Botto M; Paleolog E; Maxwell PH
Kidney Int; 2017 Oct; 92(4):900-908. PubMed ID: 28506759
[TBL] [Abstract][Full Text] [Related]
10. Structure-Activity Relationship and Crystallographic Studies on 4-Hydroxypyrimidine HIF Prolyl Hydroxylase Domain Inhibitors.
Holt-Martyn JP; Chowdhury R; Tumber A; Yeh TL; Abboud MI; Lippl K; Lohans CT; Langley GW; Figg W; McDonough MA; Pugh CW; Ratcliffe PJ; Schofield CJ
ChemMedChem; 2020 Feb; 15(3):270-273. PubMed ID: 31751494
[TBL] [Abstract][Full Text] [Related]
11. A Fluorescent Benzo[g]isoquinoline-Based HIF Prolyl Hydroxylase Inhibitor for Cellular Imaging.
Mayer M; Fey K; Heinze E; Wick CR; Abboud MI; Yeh TL; Tumber A; Orth N; Schley G; Buchholz B; Clark T; Schofield CJ; Willam C; Burzlaff N
ChemMedChem; 2019 Jan; 14(1):94-99. PubMed ID: 30380199
[TBL] [Abstract][Full Text] [Related]
12. Prolyl hydroxylase 2: a promising target to inhibit hypoxia-induced cellular metabolism in cancer cells.
Singh L; Aldosary S; Saeedan AS; Ansari MN; Kaithwas G
Drug Discov Today; 2018 Nov; 23(11):1873-1882. PubMed ID: 29772209
[TBL] [Abstract][Full Text] [Related]
13. FDA approves first hypoxia-inducible factor prolyl hydroxylase inhibitor.
Mullard A
Nat Rev Drug Discov; 2023 Mar; 22(3):173. PubMed ID: 36759582
[No Abstract] [Full Text] [Related]
14. Daprodustat: First Approval.
Dhillon S
Drugs; 2020 Sep; 80(14):1491-1497. PubMed ID: 32880805
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia-inducible factor prolyl 4-hydroxylase inhibition in cardiometabolic diseases.
Koivunen P; Serpi R; Dimova EY
Pharmacol Res; 2016 Dec; 114():265-273. PubMed ID: 27832958
[TBL] [Abstract][Full Text] [Related]
16. Evidence for the slow reaction of hypoxia-inducible factor prolyl hydroxylase 2 with oxygen.
Flashman E; Hoffart LM; Hamed RB; Bollinger JM; Krebs C; Schofield CJ
FEBS J; 2010 Oct; 277(19):4089-99. PubMed ID: 20840591
[TBL] [Abstract][Full Text] [Related]
17. Selective inhibition of the hypoxia-inducible factor prolyl hydroxylase PHD3 by Zn(II).
Na YR; Woo DJ; Choo H; Chung HS; Yang EG
Chem Commun (Camb); 2015 Jul; 51(53):10730-3. PubMed ID: 26051901
[TBL] [Abstract][Full Text] [Related]
18. Mannose Binding Lectin Is Hydroxylated by Collagen Prolyl-4-hydroxylase and Inhibited by Some PHD Inhibitors.
Bhute VJ; Harte J; Houghton JW; Maxwell PH
Kidney360; 2020 Jun; 1(6):447-457. PubMed ID: 35368589
[TBL] [Abstract][Full Text] [Related]
19. Catalytic properties of the asparaginyl hydroxylase (FIH) in the oxygen sensing pathway are distinct from those of its prolyl 4-hydroxylases.
Koivunen P; Hirsilä M; Günzler V; Kivirikko KI; Myllyharju J
J Biol Chem; 2004 Mar; 279(11):9899-904. PubMed ID: 14701857
[TBL] [Abstract][Full Text] [Related]
20. Collagen Peptides as a Hypoxia-Inducible Factor-2α-Stabilizing Prolyl Hydroxylase Inhibitor to Stimulate Intestinal Iron Absorption by Upregulating Iron Transport Proteins.
Zhu S; Wu L; Zhang M; Li S; Xing W; Zhao Z; Guo H; Ma L; Wu H
J Agric Food Chem; 2022 Dec; 70(48):15095-15103. PubMed ID: 36475394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
